Trivitron Healthcare aims to become the most respected and admirable global leader in medical instrument and devices segment with focus on emerging markets. In order to achieve this goal, Trivitron expands its presence to the critical life support solution (CLSS) segment which includes solutions and products for intensive care, operating room, dialysis care and cardiac care solutions like ventilator, patient monitor, defibrillator, ECG machine, stress test system, holter system, operating room design and execution, pendants, dialysis machine etc.
The medical technology market is ever growing due to healthcare requirements, changing life style and disease factored to it, increase in purchase power, medical tourism etc. The total market size of medical equipment and devices is approximately Rs 17000 crore of which critical life support solutions’ share is approximately Rs 3000 crore. Thus, CLSS forms almost one-third of the total market the segment is expected to grow at 15-20 per cent per annum during next five years.
Trivitron has been present in this segment since 1999, wherein it distributed products like ventilators from Hamilton; patient monitors and defib from Nihon Kohden; dialysis m/c- by Fresenius. By introducing its new segment CLSS, Trivitron now focuses on realigning its sub divisions, with its own manufactured products under one division.
“Critical Life support solution (CLSS) segment is a long term prospect for us, as operating room and intensive care are the most essential and basic needs for any corporate hospital. Trivitron has always worked towards building affordable and accessible healthcare in India. This initiative only enables us to focus on the most crucial solution requirement for healthcare” says Dr GSK Velu, Founder and MD of Trivitron Healthcare .
EH News Bureau
